The IVS4+4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients

被引:52
作者
Futaki, M
Yamashita, T
Yagasaki, H
Toda, T
Yabe, M
Kato, S
Asano, S
Nakahata, T
机构
[1] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Inst Med Sci, Dept Pediat, Minato Ku, Tokyo 1088639, Japan
[3] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med, Tokyo 1088639, Japan
[4] Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 25911, Japan
关键词
D O I
10.1182/blood.V95.4.1493.004k35_1493_1498
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and a susceptibility to leukemia. There are at least 8 complementation groups (A through H), Extensive analyses of the FA group C gene FANCC in Western countries revealed that 10% to 15% of FA patients have mutations of this gene. The most common mutation is IVS4 + 4A to T (IVS4), a splice mutation in intron 4, which has been found only in patients of Ashkenazi Jewish ancestry. When we screened 29 Japanese patients (20 unrelated patients and 4 families) using polymerase chain reaction-single strand conformation polymorphism, we found 8 unrelated patients homozygous for IVS4. This is apparently the first non-Ashkenazi-Jewish population for whom this mutation has been detected. The Ashkenazi Jewish patients homozygous for IVS4 have a severe phenotype, in comparison with other FA patients. Our analyses of Japanese patients indicate no significant difference between IVS4 homozygotes and other patients with regard to severity of a clinical phenotype. Thus, ethnic background may have a significant effect on a clinical phenotype in FA patients carrying the same mutation. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:1493 / 1498
页数:6
相关论文
共 39 条
  • [1] FANCONI-ANEMIA AND ITS VARIABILITY
    ALTER, BP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (01) : 9 - 14
  • [2] Positional cloning of the Fanconi anaemia group A gene
    Apostolou, S
    Whitmore, SA
    Crawford, J
    Lennon, G
    Sutherland, GR
    Callen, DF
    Ianzano, L
    Savino, M
    DApolito, M
    Notarangelo, A
    Memeo, E
    Piemontese, MR
    Zelante, L
    Savoia, A
    Gibson, RA
    Tipping, AJ
    Morgan, NV
    Hassock, S
    Jansen, S
    deRavel, TJ
    VanBerkel, C
    Pronk, JC
    Easton, DF
    Mathew, CG
    Levran, O
    Verlander, PC
    Batish, SD
    Erlich, T
    Auerbach, AD
    CletonJansen, AM
    Moerland, EW
    Cornelisse, CJ
    Doggett, NA
    Deaven, LL
    Moyzis, RK
    [J]. NATURE GENETICS, 1996, 14 (03) : 324 - 328
  • [3] AUERBACH AD, 1989, BLOOD, V73, P39
  • [4] DAHL N, 1990, AM J HUM GENET, V47, P275
  • [5] Fanconi anaemia forges a novel pathway
    DAndrea, AD
    [J]. NATURE GENETICS, 1996, 14 (03) : 240 - 242
  • [6] Molecular biology of Fanconi anemia: Implications for diagnosis and therapy
    DAndrea, AD
    Grompe, M
    [J]. BLOOD, 1997, 90 (05) : 1725 - 1736
  • [7] The Fanconi anaemia group G gene FANCG is identical with XRCC9
    de Winter, JP
    Waisfisz, Q
    Rooimans, MA
    van Berkel, CGM
    Bosnoyan-Collins, L
    Alon, N
    Carreau, M
    Bender, O
    Demuth, I
    Schindler, D
    Pronk, JC
    Arwert, F
    Hoehn, H
    Digweed, M
    Buchwald, M
    Joenje, H
    [J]. NATURE GENETICS, 1998, 20 (03) : 281 - 283
  • [8] ANALYSIS OF 133 MEIOSES PLACES THE GENES FOR NEVOID BASAL-CELL CARCINOMA (GORLIN)-SYNDROME AND FANCONI-ANEMIA GROUP-C IN A 2.6-CM INTERVAL AND CONTRIBUTES TO THE FINE MAP OF 9Q22.3
    FARNDON, PA
    MORRIS, DJ
    HARDY, C
    MCCONVILLE, CM
    WEISSENBACH, J
    KILPATRICK, MW
    REIS, A
    [J]. GENOMICS, 1994, 23 (02) : 486 - 489
  • [9] Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866
  • [10] Gibson RA, 1996, HUM MUTAT, V8, P140, DOI 10.1002/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO